I am a hematologist focused on the care of patients with plasma cell disorders and dysproteinemias such as multiple myeloma, smoldering multiple myeloma/asymptomatic multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, light chain (AL) amyloidosis, POEMS syndrome, and monoclonal immunoglobulin/light chain deposition disease (MIDD). I am interested in clinical research and development of clinical trials of novel drugs and novel drug combinations for patients with these disorders. I am committed to providing compassionate patient-centered care for patients with myeloma and other plasma cell disorders.